Digital Patient Support Program for Self-efficacy and Medication Adherence in Women on Adjuvant Endocrine Treatment for Breast Cancer
Launched by SIDEKICK HEALTH · May 16, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how a digital support program called Sidekick Health can help women with breast cancer who are receiving hormone therapy. The main goal is to see if using this app can boost their confidence in managing their health and help them stick to their medication plans better. Participants will be divided into two groups: one will use the Sidekick app along with their usual medical care, while the other will only receive standard care.
To join the study, women must be at least 18 years old, diagnosed with early-stage breast cancer (stages I, II, or III), and currently prescribed hormone therapy. They should also speak either Icelandic or English, have a smartphone that can use the Sidekick app, and be willing to participate fully. Throughout the trial, participants can expect regular check-ins and support to help them use the app effectively. This study is currently recruiting, and it's a unique opportunity to potentially enhance the treatment experience for women battling breast cancer.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Adult patient (18 years or older) diagnosed with breast cancer of stage I, II or III from 1st September 2023 or later
- • Have been prescribed adjuvant endocrine therapy for breast cancer.
- • Understands written and spoken Icelandic or English.
- • Owns a smart-phone compatible with the Sidekick app and capable to use it
- • Willing to download the Sidekick app on the smart-phone and to comply with the study measures and visits according to the protocol.
- • Capable of providing informed consent for participating in the study.
- Exclusion Criteria:
- • Having other concurrent conditions that in the opinion of the oncologist may compromise patient safety or study objectives.
- • Concurrent participation in another clinical study in which the study treatment may confound the evaluation of the investigational program.
- • Metastatic breast cancer (stage IV)
- • Previous experience with Sidekick breast cancer program
About Sidekick Health
Sidekick Health is an innovative digital health company dedicated to transforming the patient experience through personalized, gamified interventions. By leveraging advanced technology and behavioral science, Sidekick Health develops digital therapeutics that empower individuals to manage their health conditions effectively. Their clinical trial initiatives focus on evaluating the efficacy and usability of these solutions, aiming to enhance patient engagement, adherence, and overall health outcomes. Committed to evidence-based practices, Sidekick Health collaborates with healthcare professionals and institutions to drive advancements in the field of digital health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reykjavik, , Iceland
Patients applied
Trial Officials
Olof Kristjana Bjarnadottir, MD, PhD
Principal Investigator
Landspitali University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported